These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 6086364)
21. Sustained depletion of cortical and hippocampal serotonin and norepinephrine but not striatal dopamine by 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH2-MPTP): a comparative study with 2'-CH3-MPTP and MPTP. Andrews AM; Murphy DL J Neurochem; 1993 Mar; 60(3):1167-70. PubMed ID: 8094744 [TBL] [Abstract][Full Text] [Related]
22. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Sirinathsinghji DJ; Whittington PE; Audsley AR Brain Res; 1986 Dec; 399(2):339-45. PubMed ID: 2435361 [TBL] [Abstract][Full Text] [Related]
23. Attenuation of MPTP-induced dopaminergic neurotoxicity by a serotonin uptake blocker. Brooks WJ; Jarvis MF; Wagner GC J Neural Transm; 1988; 71(2):85-90. PubMed ID: 3258013 [TBL] [Abstract][Full Text] [Related]
24. Synthetic analgesics and other phenylpiperidines: effects on uptake and storage of dopamine and other monoamines mouse forebrain tissue. Baldessarini RJ; Kula NS; Francoeur D; Finklestein SP; Murphy F; Neumeyer JL Life Sci; 1986 Nov; 39(19):1765-77. PubMed ID: 3490612 [TBL] [Abstract][Full Text] [Related]
25. Pharmacological effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal dopamine receptor system. Lau YS; Fung YK Brain Res; 1986 Mar; 369(1-2):311-5. PubMed ID: 3486026 [TBL] [Abstract][Full Text] [Related]
26. Effect of MPTP and its pyridinium metabolites on monoamine uptake and on central catecholamine neurons in mice. Jonsson G; Nwanze E; Luthman J; Sundström E Acta Physiol Scand; 1986 Oct; 128(2):187-94. PubMed ID: 3535380 [TBL] [Abstract][Full Text] [Related]
27. MPP+ (1-methyl-4-phenylpyridine) is a neurotoxin to dopamine-, norepinephrine- and serotonin-containing neurons. Namura I; Douillet P; Sun CJ; Pert A; Cohen RM; Chiueh CC Eur J Pharmacol; 1987 Apr; 136(1):31-7. PubMed ID: 3496229 [TBL] [Abstract][Full Text] [Related]
29. The protective effect of 1-tert.butyl-4,4-diphenylpiperidine against the nigrostriatal neurodegeneration caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Przuntek H; Russ H; Henning K; Pindur U Life Sci; 1985 Sep; 37(13):1195-200. PubMed ID: 2413325 [TBL] [Abstract][Full Text] [Related]
30. The neurochemical and clinical effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in small animals. Donnan GA; Kaczmarczyk SJ; Solopotias T; Rowe P; Kalnins RM; Vajda FJ; Mendelsohn FA Clin Exp Neurol; 1986; 22():155-64. PubMed ID: 3495376 [TBL] [Abstract][Full Text] [Related]
31. A simple quantitative bradykinesia test in MPTP-treated mice. Ogawa N; Hirose Y; Ohara S; Ono T; Watanabe Y Res Commun Chem Pathol Pharmacol; 1985 Dec; 50(3):435-41. PubMed ID: 3878557 [TBL] [Abstract][Full Text] [Related]
32. MPTP alters central catecholamine neurons in addition to the nigrostriatal system. Gupta M; Felten DL; Gash DM Brain Res Bull; 1984 Dec; 13(6):737-42. PubMed ID: 6335836 [TBL] [Abstract][Full Text] [Related]
33. Fluoxetine and desipramine selectively attenuate 2'-NH2-MPTP-induced depletions in serotonin and norepinephrine. Andrews AM; Murphy DL Eur J Pharmacol; 1993 Dec; 250(2):215-21. PubMed ID: 8112382 [TBL] [Abstract][Full Text] [Related]
34. Neuronal and astroglial responses to the serotonin and norepinephrine neurotoxin: 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine. Luellen BA; Miller DB; Chisnell AC; Murphy DL; O'Callaghan JP; Andrews AM J Pharmacol Exp Ther; 2003 Dec; 307(3):923-31. PubMed ID: 14561848 [TBL] [Abstract][Full Text] [Related]
35. Reversible serotoninergic neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse striatum studied by neurochemical and immunohistochemical approaches. Hara K; Tohyama I; Kimura H; Fukuda H; Nakamura S; Kameyama M Brain Res; 1987 May; 410(2):371-4. PubMed ID: 3297254 [TBL] [Abstract][Full Text] [Related]
36. Regional and temporal effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine uptake sites in mouse brain. Donnan GA; Kaczmarczyk SJ; McKenzie JS; Rowe PJ; Kalnins RM; Mendelsohn FA J Neurol Sci; 1987 Nov; 81(2-3):261-71. PubMed ID: 3501002 [TBL] [Abstract][Full Text] [Related]
37. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors. Heikkila RE; Manzino L; Cabbat FS; Duvoisin RC Nature; 1984 Oct 4-10; 311(5985):467-9. PubMed ID: 6332989 [TBL] [Abstract][Full Text] [Related]
38. Depletion of heart norepinephrine in mice by some analogs of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine). Fuller RW; Hemrick-Luecke SK Res Commun Chem Pathol Pharmacol; 1987 May; 56(2):147-56. PubMed ID: 3496637 [TBL] [Abstract][Full Text] [Related]
39. Effect of MPTP on Serotonergic Neuronal Systems and Mitochondrial Complex I Activity in the Living Brain: A PET Study on Conscious Rhesus Monkeys. Kanazawa M; Ohba H; Nishiyama S; Kakiuchi T; Tsukada H J Nucl Med; 2017 Jul; 58(7):1111-1116. PubMed ID: 28280215 [TBL] [Abstract][Full Text] [Related]
40. Comparative studies of the neurotoxicity of MPTP in rats of different ages. Lee EH; Liu SP; Lu KT; Lin WR Chin J Physiol; 1992; 35(4):317-36. PubMed ID: 1364057 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]